Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center, explains how older patients with glaucoma may lose nerve fiber layer at a quicker rate than younger patients.
The search for safer surgical options for our older patients remains an unment need in glaucoma care, said Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center.
Transcript
What are the next steps for understanding and implementing the best medical and surgical practices or managment patterns for older patients with glaucome?
I think the next step is ongoing research to find safer alternatives, and in many cases safer surgical alternatives than traditional surgeries such as trabeculectomy and glaucoma drainage device procedures, which are rife with more complications. There's a whole class of surgeries called MIGS, minimally invasive glaucoma surgeries, that are directed in lowering patients' eye pressure, with fewer complications. There are lots of different MIGS options, but there's still not one out there that can lower the patient's pressure as low as a standard trabeculectomy can. So I think the search for safer surgical options for our elderly patients is an area that has this unmet need for our practices.
Do you have any closing thoughts you'd like to share?
Based on some of the work out of Duke, when you look at an older population glaucoma patient vs a younger population, we find that older patients may lose nerve fiber layer at a quicker rate than their younger counterparts. So we may need to rethink our process of being less aggressive in an older patient and really pay attention to how their visual fields are progressing in a nerve fiber layer analysis and present what're the surgical options that patients need to have that.
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Designing Care for the Underserved Creates Higher-Value Health Solutions
January 12th 2025In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.
Read More
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More